Epidemiology

Lead a more targeted approach to drug development, testing and commercialization by understanding the size of your addressable patient population in terms of the incidence, prevalence and spread of disease.

Learn more Use cases

Prevalence of non-alcoholic steatohepatitis (NASH) since 2012

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Definition

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ultrices dui sapien eget mi proin sed libero enim sed.

Criteria

Lorem ipsum dolor sit amet.

Power your decision-making

with bespoke and intuitive intelligence boards

VISFO combines cutting-edge technology and deep subject matter expertise to de-silo data and enable confident decision-making. With all outputs housed in an agile, always-on delivery portal, you can quickly:

Visualize

No items found.

Identify

Disease prevalence and incidence
Disease risk factors
Mortality and morbidity rates
Surveillance trends
Population demographics

‍

Analyze

Insights at a regional, state, or country level
Demographic trends and disparities within, e.g., different age, sex, race and ethnicity categories
Disease causation and comorbidity relationships, aided by filters for disease etiology and risk factors

Maintain a clear view of the dynamics of disease distribution over the entire lifecycle of your product with user-defined data updates.

‍

Use cases

Estimate the market size for a new therapy to assess commercial opportunity

Tailor access strategies, justify pricing decisions and negotiate reimbursement agreements

Inform Health Economics and Outcomes Research (HEOR)

Determine the size and characteristics of the patient population most likely to benefit from an intervention

Select clinically relevant endpoints, outcome measures and comparators for clinical trials

Facilitate clinical trial recruitment by identifying regions or populations with high disease prevalence

Leverage real-world evidence (RWE) to complement clinical trial data, evaluate treatment effectiveness in real-world settings and inform clinical decision-making

Develop educational materials about disease prevalence, risk factors and treatment options

Support scientific communications and publications

Delivered through Helix

Modular knowledge base

Interactive data visualizations for easy self-serve analysis and insight surfacing
Comprehensive opinion leader profiles for effective interaction planning and engagement
Multiple data export options for rapid insight sharing across your business
Customizable, modular knowledge bases with no user limits

Explore Helix

A VISFO "Key Opinion Leader (KOL) intelligence board" displayed on both a desktop and mobile screen. The board includes an interactive KOL map, as well as the results of a KOL influence analysis."